Search results
Dec 23, 2020 · As the COVID-19 pandemic threatens the delivery of malaria services, such as the distribution of insecticide-treated nets (ITNs), indoor residual spraying, as well as malaria chemoprevention there is an urgent need for rapid and effective responses to avoid malaria outbreaks.
- Mogahed Ismail Hassan Hussein, Ahmed Abdalazim Dafallah Albashir, Omer Ali Mohamed Ahmed Elawad, Anm...
- 2020
Sep 6, 2020 · Malaria and COVID-19 share symptoms and geographic areas of disease spread. The use of laboratory investigations, and therefore the availability of adequate diagnostic capacity, as well as careful clinical surveillance and management of cases appear crucial in differential diagnosis.
- Francesco Di Gennaro, Claudia Marotta, Pietro Locantore, Damiano Pizzol, Giovanni Putoto
- 2020
- Chloroquine and Hydroxychloroquine
- Remdesivir
- Ritonavir and Lopinavir
- Immune System Inhibitors
- Convalescent Plasma
President Donald Trump has repeatedly touted the malaria drugs chloroquine and hydroxychloroquine as a treatment for COVID-19—despite a lack of clinical evidence that they work for the disease. The president’s comments set off a scramble among doctors and patients to obtain the drugs—which are frequently used to treat autoimmune diseases such as rh...
This experimental antiviral drug was developed to treat Ebola, and it has been shown to be safe for use in humans. It is a broad-spectrum antiviral that blocks replication in several other coronaviruses, according to studies in mice and in cells grown in a lab. In addition to the WHO investigation, at least twotrials in China and one in the U.S. ar...
The HIV drugs ritonavir and lopinavir (sold as a combination therapy by AbbVie under the brand name Kaletra) have been tested against COVID-19 in a few clinical trials. The initial data have not shown them to be effective, however. A study in the New England Journal of Medicinefound they conferred no benefit beyond standard care. The drug combinati...
Researchers are also considering a number of other therapies that tamp down the rampant immune response seen in severe COVID-19 cases. Such a flood of immune cells in the lungs—known as a cytokine storm—can lead to death. Many of the sickest patients have elevated levels of an inflammatory protein called interleukin-6 (IL-6). Research in China has ...
Another treatment approach involves injecting COVID-19 patients with blood plasma from people who have recovered from the illness. The FDA recently issued guidance on the investigational use of such “convalescent plasma,” which contains antibodies to the coronavirus, and clinical trialsare underway. Blood from disease survivors has been used as a t...
Apr 23, 2020 · A panel of experts convened by the National Institute of Allergy and Infectious Diseases has recommended against using a combination of hydroxychloroquine and the antibiotic azithromycin for the treatment of COVID-19 patients because of potential toxicities. Learn more.
Aug 12, 2020 · An old antimalarial medication chloroquine (CQ), and its derivative Hydroxychloroquine (HCQ), have become increasingly popular in the attempt to find an effective treatment for COVID-19, especially after being endorsed by the U.S. president in March 2020.
- Biplab K. Saha, Alyssa Bonnier, Woon Chong
- 10.1016/j.amjms.2020.08.019
- 2020
- Am J Med Sci. 2020 Dec; 360(6): 618-630.
Feb 3, 2023 · In this study, “barriers to malaria control” were defined as obstacles that restrain interventions for malaria prevention, diagnosis, and treatment that are planned or implemented during the COVID-19 pandemic in LMICs.
Apr 10, 2020 · Are malaria drugs effective against COVID-19? In late March, the U.S. Food and Drug Administration (FDA) authorized the emergency release of federal supplies of two drugs, typically used to treat malaria, for use with COVID-19 patients: hydroxychloroquine and chloroquine.
